Cargando…
Oncologists' Perspective: When Cancer Encounters COVID‐19
Considering that the course of the COVID‐19 pandemic remains to be seen, this letter to the editor considers that longstanding structural changes that may be required in oncology institutions.
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272896/ https://www.ncbi.nlm.nih.gov/pubmed/32412653 http://dx.doi.org/10.1634/theoncologist.2020-0296 |
_version_ | 1783542323953532928 |
---|---|
author | Gao, Zhaoya Yang, Yong Ding, Changmin Niu, Pengfei Huang, Wensheng Lei, Fuming Gu, Jin |
author_facet | Gao, Zhaoya Yang, Yong Ding, Changmin Niu, Pengfei Huang, Wensheng Lei, Fuming Gu, Jin |
author_sort | Gao, Zhaoya |
collection | PubMed |
description | Considering that the course of the COVID‐19 pandemic remains to be seen, this letter to the editor considers that longstanding structural changes that may be required in oncology institutions. |
format | Online Article Text |
id | pubmed-7272896 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72728962020-06-05 Oncologists' Perspective: When Cancer Encounters COVID‐19 Gao, Zhaoya Yang, Yong Ding, Changmin Niu, Pengfei Huang, Wensheng Lei, Fuming Gu, Jin Oncologist Letters to the Editor Considering that the course of the COVID‐19 pandemic remains to be seen, this letter to the editor considers that longstanding structural changes that may be required in oncology institutions. John Wiley & Sons, Inc. 2020-07-07 2020-09 /pmc/articles/PMC7272896/ /pubmed/32412653 http://dx.doi.org/10.1634/theoncologist.2020-0296 Text en © AlphaMed Press 2020 |
spellingShingle | Letters to the Editor Gao, Zhaoya Yang, Yong Ding, Changmin Niu, Pengfei Huang, Wensheng Lei, Fuming Gu, Jin Oncologists' Perspective: When Cancer Encounters COVID‐19 |
title | Oncologists' Perspective: When Cancer Encounters COVID‐19 |
title_full | Oncologists' Perspective: When Cancer Encounters COVID‐19 |
title_fullStr | Oncologists' Perspective: When Cancer Encounters COVID‐19 |
title_full_unstemmed | Oncologists' Perspective: When Cancer Encounters COVID‐19 |
title_short | Oncologists' Perspective: When Cancer Encounters COVID‐19 |
title_sort | oncologists' perspective: when cancer encounters covid‐19 |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272896/ https://www.ncbi.nlm.nih.gov/pubmed/32412653 http://dx.doi.org/10.1634/theoncologist.2020-0296 |
work_keys_str_mv | AT gaozhaoya oncologistsperspectivewhencancerencounterscovid19 AT yangyong oncologistsperspectivewhencancerencounterscovid19 AT dingchangmin oncologistsperspectivewhencancerencounterscovid19 AT niupengfei oncologistsperspectivewhencancerencounterscovid19 AT huangwensheng oncologistsperspectivewhencancerencounterscovid19 AT leifuming oncologistsperspectivewhencancerencounterscovid19 AT gujin oncologistsperspectivewhencancerencounterscovid19 |